The role of fibroblast growth factor-2 in the vascular effects ofinterleukin-1β in porcine coronary arteries in vivo

Akira Ito, Hiroaki Shimokawa, Yoshihiro Fukumoto, Toshiaki Kadokami, Ryuichi Nakaike, Tsuneo Takayanagi, Kensuke Egashira, Katsuo Sueishi, Akira Takeshita

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: We recently demonstrated that chronic treatment with interleukin-1β (IL-1β), a major inflammatory cytokine found in atherosclerotic lesions, induces coronary arteriosclerotic changes and vasospastic responses to serotonin and histamine in pigs in vivo and that those responses are partially mediated by platelet-derived growth factor (PDGF). This study was designed to examine, first, whether the effects of IL-1β are also partially mediated by fibroblast growth factor-2 (FGF-2), which is another important growth factor in atherosclerotic lesions, and, secondly, whether chronic treatment with FGF-2 per se also induces histological and functional changes in porcine coronary arteries in vivo. Methods: Porcine coronary arteries were aseptically wrapped with cotton mesh absorbing IL-1β with or without neutralizing antibody to FGF-2. In a separate series of experiments porcine coronary arteries were chronically treated with FGF-2 itself in the same manner. Coronary vascular responses in vivo and histological changes were examined 2 weeks after the operation. Results: Coronary vasospastic responses to serotonin and histamine and neointimal formation were induced at the site of the coronary artery where IL-1β was chronically and locally applied. These responses were significantly suppressed by co-treatment with a neutralizing antibody to FGF-2 but not by that with non-immune IgG. Immunostaining revealed the presence of FGF-2 in the endothelial cells, the thickened intima and the media at the IL-1 β-treated site. Furthermore, chronic treatment with FGF-2 also induced coronary vasospastic responses to serotonin and histamine and neointimal formation. Conclusions: These results suggest that the vascular effects of IL-1β may also be mediated by FGF-2 in our swine model and that chronic treatment with FGF-2 also causes coronary arteriosclerotic changes and vasospastic responses in vivo.

Original languageEnglish
Pages (from-to)570-579
Number of pages10
JournalCardiovascular research
Volume32
Issue number3
DOIs
Publication statusPublished - Sep 1 1996

Fingerprint

Fibroblast Growth Factor 2
Blood Vessels
Coronary Vessels
Swine
Interleukin-1
Histamine
Serotonin
Neutralizing Antibodies
Platelet-Derived Growth Factor
Intercellular Signaling Peptides and Proteins
Endothelial Cells
Immunoglobulin G
Cytokines

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Ito, A., Shimokawa, H., Fukumoto, Y., Kadokami, T., Nakaike, R., Takayanagi, T., ... Takeshita, A. (1996). The role of fibroblast growth factor-2 in the vascular effects ofinterleukin-1β in porcine coronary arteries in vivo. Cardiovascular research, 32(3), 570-579. https://doi.org/10.1016/0008-6363(96)00120-4

The role of fibroblast growth factor-2 in the vascular effects ofinterleukin-1β in porcine coronary arteries in vivo. / Ito, Akira; Shimokawa, Hiroaki; Fukumoto, Yoshihiro; Kadokami, Toshiaki; Nakaike, Ryuichi; Takayanagi, Tsuneo; Egashira, Kensuke; Sueishi, Katsuo; Takeshita, Akira.

In: Cardiovascular research, Vol. 32, No. 3, 01.09.1996, p. 570-579.

Research output: Contribution to journalArticle

Ito, A, Shimokawa, H, Fukumoto, Y, Kadokami, T, Nakaike, R, Takayanagi, T, Egashira, K, Sueishi, K & Takeshita, A 1996, 'The role of fibroblast growth factor-2 in the vascular effects ofinterleukin-1β in porcine coronary arteries in vivo', Cardiovascular research, vol. 32, no. 3, pp. 570-579. https://doi.org/10.1016/0008-6363(96)00120-4
Ito, Akira ; Shimokawa, Hiroaki ; Fukumoto, Yoshihiro ; Kadokami, Toshiaki ; Nakaike, Ryuichi ; Takayanagi, Tsuneo ; Egashira, Kensuke ; Sueishi, Katsuo ; Takeshita, Akira. / The role of fibroblast growth factor-2 in the vascular effects ofinterleukin-1β in porcine coronary arteries in vivo. In: Cardiovascular research. 1996 ; Vol. 32, No. 3. pp. 570-579.
@article{bacabc2ea7c942c7991851b6f4076fa5,
title = "The role of fibroblast growth factor-2 in the vascular effects ofinterleukin-1β in porcine coronary arteries in vivo",
abstract = "Objective: We recently demonstrated that chronic treatment with interleukin-1β (IL-1β), a major inflammatory cytokine found in atherosclerotic lesions, induces coronary arteriosclerotic changes and vasospastic responses to serotonin and histamine in pigs in vivo and that those responses are partially mediated by platelet-derived growth factor (PDGF). This study was designed to examine, first, whether the effects of IL-1β are also partially mediated by fibroblast growth factor-2 (FGF-2), which is another important growth factor in atherosclerotic lesions, and, secondly, whether chronic treatment with FGF-2 per se also induces histological and functional changes in porcine coronary arteries in vivo. Methods: Porcine coronary arteries were aseptically wrapped with cotton mesh absorbing IL-1β with or without neutralizing antibody to FGF-2. In a separate series of experiments porcine coronary arteries were chronically treated with FGF-2 itself in the same manner. Coronary vascular responses in vivo and histological changes were examined 2 weeks after the operation. Results: Coronary vasospastic responses to serotonin and histamine and neointimal formation were induced at the site of the coronary artery where IL-1β was chronically and locally applied. These responses were significantly suppressed by co-treatment with a neutralizing antibody to FGF-2 but not by that with non-immune IgG. Immunostaining revealed the presence of FGF-2 in the endothelial cells, the thickened intima and the media at the IL-1 β-treated site. Furthermore, chronic treatment with FGF-2 also induced coronary vasospastic responses to serotonin and histamine and neointimal formation. Conclusions: These results suggest that the vascular effects of IL-1β may also be mediated by FGF-2 in our swine model and that chronic treatment with FGF-2 also causes coronary arteriosclerotic changes and vasospastic responses in vivo.",
author = "Akira Ito and Hiroaki Shimokawa and Yoshihiro Fukumoto and Toshiaki Kadokami and Ryuichi Nakaike and Tsuneo Takayanagi and Kensuke Egashira and Katsuo Sueishi and Akira Takeshita",
year = "1996",
month = "9",
day = "1",
doi = "10.1016/0008-6363(96)00120-4",
language = "English",
volume = "32",
pages = "570--579",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - The role of fibroblast growth factor-2 in the vascular effects ofinterleukin-1β in porcine coronary arteries in vivo

AU - Ito, Akira

AU - Shimokawa, Hiroaki

AU - Fukumoto, Yoshihiro

AU - Kadokami, Toshiaki

AU - Nakaike, Ryuichi

AU - Takayanagi, Tsuneo

AU - Egashira, Kensuke

AU - Sueishi, Katsuo

AU - Takeshita, Akira

PY - 1996/9/1

Y1 - 1996/9/1

N2 - Objective: We recently demonstrated that chronic treatment with interleukin-1β (IL-1β), a major inflammatory cytokine found in atherosclerotic lesions, induces coronary arteriosclerotic changes and vasospastic responses to serotonin and histamine in pigs in vivo and that those responses are partially mediated by platelet-derived growth factor (PDGF). This study was designed to examine, first, whether the effects of IL-1β are also partially mediated by fibroblast growth factor-2 (FGF-2), which is another important growth factor in atherosclerotic lesions, and, secondly, whether chronic treatment with FGF-2 per se also induces histological and functional changes in porcine coronary arteries in vivo. Methods: Porcine coronary arteries were aseptically wrapped with cotton mesh absorbing IL-1β with or without neutralizing antibody to FGF-2. In a separate series of experiments porcine coronary arteries were chronically treated with FGF-2 itself in the same manner. Coronary vascular responses in vivo and histological changes were examined 2 weeks after the operation. Results: Coronary vasospastic responses to serotonin and histamine and neointimal formation were induced at the site of the coronary artery where IL-1β was chronically and locally applied. These responses were significantly suppressed by co-treatment with a neutralizing antibody to FGF-2 but not by that with non-immune IgG. Immunostaining revealed the presence of FGF-2 in the endothelial cells, the thickened intima and the media at the IL-1 β-treated site. Furthermore, chronic treatment with FGF-2 also induced coronary vasospastic responses to serotonin and histamine and neointimal formation. Conclusions: These results suggest that the vascular effects of IL-1β may also be mediated by FGF-2 in our swine model and that chronic treatment with FGF-2 also causes coronary arteriosclerotic changes and vasospastic responses in vivo.

AB - Objective: We recently demonstrated that chronic treatment with interleukin-1β (IL-1β), a major inflammatory cytokine found in atherosclerotic lesions, induces coronary arteriosclerotic changes and vasospastic responses to serotonin and histamine in pigs in vivo and that those responses are partially mediated by platelet-derived growth factor (PDGF). This study was designed to examine, first, whether the effects of IL-1β are also partially mediated by fibroblast growth factor-2 (FGF-2), which is another important growth factor in atherosclerotic lesions, and, secondly, whether chronic treatment with FGF-2 per se also induces histological and functional changes in porcine coronary arteries in vivo. Methods: Porcine coronary arteries were aseptically wrapped with cotton mesh absorbing IL-1β with or without neutralizing antibody to FGF-2. In a separate series of experiments porcine coronary arteries were chronically treated with FGF-2 itself in the same manner. Coronary vascular responses in vivo and histological changes were examined 2 weeks after the operation. Results: Coronary vasospastic responses to serotonin and histamine and neointimal formation were induced at the site of the coronary artery where IL-1β was chronically and locally applied. These responses were significantly suppressed by co-treatment with a neutralizing antibody to FGF-2 but not by that with non-immune IgG. Immunostaining revealed the presence of FGF-2 in the endothelial cells, the thickened intima and the media at the IL-1 β-treated site. Furthermore, chronic treatment with FGF-2 also induced coronary vasospastic responses to serotonin and histamine and neointimal formation. Conclusions: These results suggest that the vascular effects of IL-1β may also be mediated by FGF-2 in our swine model and that chronic treatment with FGF-2 also causes coronary arteriosclerotic changes and vasospastic responses in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0030245555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030245555&partnerID=8YFLogxK

U2 - 10.1016/0008-6363(96)00120-4

DO - 10.1016/0008-6363(96)00120-4

M3 - Article

C2 - 8881517

AN - SCOPUS:0030245555

VL - 32

SP - 570

EP - 579

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 3

ER -